logo
AAT Bioquest

 
search
logo
AAT Bioquest
Contact us
Company
Telephone:1-408-733-1055
Fax:1-408-733-1304
Hours:Monday to Friday
8:30 - 17:30 PST (GMT-8)
Location:5775 W Las Positas Blvd.
Pleasanton, CA, 94588
USA

Email us
Sales:sales@aatbio.com
Technical Support:support@aatbio.com
Website:websupport@aatbio.com
General Inquiries:info@aatbio.com
Order info
United States of America
Telephone:1-408-733-1055
Fax:1-408-733-1304
Email:sales@aatbio.com
Purchase Order:sales@aatbio.com

International
Click here to see all available distributors
 
search
calculatorCalculator

cAMP-dependent protein kinase (PKA) Inhibitors (IC50, Ki)

Structure
▲
▼
Compound Name
▲
▼
Standard Type
▲
▼
Standard Values (in nM)
▲
▼
StaurosporineIC506.5 [1]
Arcyriaflavin aIC502000.0 [1], 60000.0 [2]
6,7,12,13-Tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-oneIC502000.0 [1], 25700.0 [2]
Ellagic acidIC50600.0 [1], 3500.0 [2]
N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideIC5073.0 [1], 1200.0 [2]
AlvocidibIC5050000.0 [1], 960000.0 [2]
SeliciclibIC501000000.0 [1]
N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamideIC50500000.0 [1]
(2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amineIC502.1 [1]
(1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamineIC5038.0 [1]
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine dihydrochlorideIC503500.0 [1]
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine dihydrochlorideKi3000.0 [1]
4-Methyl-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamideIC50100000.0 [1]
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamineIC50500000.0 [1]
N-[3-(4-Pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamideIC50500000.0 [1]
N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-acetamideIC50500000.0 [1]
Indolocarbazole deriv. 4bIC502000.0 [1]
Indolocarbazole deriv. 4cIC502000.0 [1]
2-Methoxy-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamideIC50500000.0 [1]
N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]naphthalene-2-carboxamideIC50100000.0 [1]
(2S)-5-(Diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-3-hydroxy-2-[3-[2-(isoquinolin-5-ylsulfonylamino)ethylamino]propanoylamino]propanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoic acidIC503.0 [1]
(2S)-5-(Diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-3-hydroxy-2-[3-[2-(isoquinolin-5-ylsulfonylamino)ethylamino]propanoylamino]propanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoic acidKi4.0 [1]
(2S)-5-(Diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-3-hydroxy-2-[[(2S)-2-[[(2S)-2-(isoquinolin-5-ylsulfonylamino)propanoyl]amino]propanoyl]amino]propanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoic acidIC50300.0 [1]
(2S)-5-(Diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-3-hydroxy-2-[[(2S)-2-[[(2S)-2-(isoquinolin-5-ylsulfonylamino)propanoyl]amino]propanoyl]amino]propanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoic acidKi170.0 [1]
4-Chloro-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamideIC50100000.0 [1]
2-[2,6-Dihydroxy-4-[(3R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acidIC5060.0 [1], 80.0 [2]
3-[(11R,15R)-13-Methyl-1,13-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-2,4,6,8-tetraen-8-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;hydrochlorideIC502800.0 [1], 5500.0 [2]
ImatinibIC50500000.0 [1]
4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazoleIC5050000.0 [1]
Bisindolylmaleimide iIC5020000.0 [1]
Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans-Ki5000.0 [1]
FasudilKi460.0 [1]
9H-Pyrido[3,4-B]indoleIC5025000.0 [1]
2,4'-DibromoacetophenoneIC50100000.0 [1]
VatalanibIC5010000.0 [1]
Bisindolylmaleimide IVIC502000.0 [1]
OlomoucineIC502000000.0 [1]
4'-N-BenzoylstaurosporineIC502400.0 [1]
(2S,3R,4R,6R,18S)-18-Hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-oneIC5042.0 [1]
(2R,3S,4S,6S,18R)-18-Hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-oneIC501150.0 [1]
SaracatinibIC5010000.0 [1]
HydroxyfasudilKi2200.0 [1]
2-BromoacetophenoneIC50100000.0 [1]
DoramapimodIC5020000.0 [1]
MinaprineIC50100000.0 [1]
Purvalanol BIC503800.0 [1]
(S)-2-Methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazineKi340.0 [1]
Purvalanol AIC509000.0 [1]
3-[(8S)-8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dioneIC50223375.0 [1]
Bisindolylmaleimide xi, HClIC505900.0 [1]
N-(6-Chloro-9h-pyrido[3,4-b]indol-8-yl)-3-pyridinecarboxamideIC5025000.0 [1]
N-(2-Aminoethyl)isoquinoline-5-sulfonamideIC502000.0 [1]
3-[8-(Aminomethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dioneIC501200.0 [1]
BalanolKi4.7 [1]
Azd-1152hqpaKi10000.0 [1]
9H-Purine-2,6-diamine, N2-(2-aminocyclohexyl)-N6-(3-chlorophenyl)-9-ethyl-, cis-IC50335000.0 [1]
PDGF Receptor Tyrosine Kinase Inhibitor IVIC50100000.0 [1]
A-674563Ki16.0 [1]
2-Bromo-4'-chloroacetophenoneIC50100000.0 [1]
4-(1H-Indol-3-yl)pyrimidin-2-amineIC50120000.0 [1]
CID 6918852Ki5000.0 [1]
1-(5-Isoquinolinesulfonyl)piperazineIC506000.0 [1]
A-770041IC5025000.0 [1]
Cdk4 InhibitorIC5020000.0 [1]
3-(2-Aminopyrimidin-4-yl)-1H-indol-4-olIC5011000.0 [1]
2,4'-DichloroacetophenoneIC50100000.0 [1]
4-(5-Bromo-1H-indol-3-yl)pyrimidin-2-amineIC50700.0 [1]
JNK Inhibitor VIIIKi7500.0 [1]
(5-Oxo-5,6-dihydro-indolo[1,2-A]quinazolin-7-YL)-acetic acidIC5016000.0 [1]
Bms-509744IC5050000.0 [1]
2-Bromo-4'-methoxyacetophenoneIC50100000.0 [1]
N-(4-Chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamideIC5010000.0 [1]
PDGF Receptor Tyrosine Kinase Inhibitor IIIIC5030000.0 [1]
5-[(2S)-2-Methylpiperazin-1-yl]sulfonylisoquinolineIC503000.0 [1]
2-Bromo-4'-phenylacetophenoneIC50100000.0 [1]
[3-[[4-(Aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]phenyl] N,N-dimethylcarbamateIC501.0 [1]
2-[(5,6-Diphenylfuro[2,3-D]pyrimidin-4-YL)amino]ethanolIC50200000.0 [1]
N'-(Pyrrolidino[2,1-B]isoindolin-4-ON-8-YL)-N-(pyridin-2-YL)ureaIC5020000.0 [1]
4-[3-Methyl-2-piperidin-4-yl-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-N-[(1S)-1-phenylethyl]pyridin-2-amineIC501500.0 [1]
CID 9916282IC50100000.0 [1]
Meridianin DIC501000.0 [1]
4-[3-Methyl-2-piperidin-4-yl-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-N-[(1S)-1-phenylethyl]pyrimidin-2-amineIC5024000.0 [1]
[4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amineKi1000.0 [1]
14-Hydroxy-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-oneIC5034000.0 [1]
3-Amino-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamideIC5027000.0 [1]
2-Chloro-1-(4,5-dibromo-2-thiophenyl)ethanoneIC50100000.0 [1]
4-(6,7-Dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)-1-piperazinecarboxamideIC5030000.0 [1]
Meridianin FIC503200.0 [1]
3-(2-Aminopyrimidin-4-yl)-6-bromo-1H-indol-4-olIC50210.0 [1]
N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamideKi7500.0 [1]
N-Benzyl-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamideIC5030000.0 [1]
3-(4'-Hydroxybiphenyl-4-Yl)-N-(4-Hydroxycyclohexyl)-1,4-Dihydroindeno[1,2-C]pyrazole-6-CarboxamideIC5050000.0 [1]
4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamideKi7500.0 [1]
Eudistomin NIC5025000.0 [1]
3-(4-Morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol;hydrochlorideIC503400.0 [1]
8-Bromo-4-(3-chloro-4-fluoroanilino)-6-[(1-methylimidazol-4-yl)methylamino]quinoline-3-carbonitrileIC50100000.0 [1]
2-Chloro-1-(3,4-dibromo-2-thienyl)-1-ethanoneIC50100000.0 [1]
4-[(4-Methyl-1-piperazinyl)methyl]-N-[3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamideIC50475000.0 [1]
3-Methyl-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaene-12,14-dioneIC5020000.0 [1]
3-[[5-[6-[(3-Chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanolIC5010000.0 [1]
Items per page: 1 - 10 of 100
⟨⟩

References

This online tool may be cited as follows

MLA

"Quest Database™ cAMP-dependent protein kinase (PKA) Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/camp-dependent-protein-kinase-pka-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024, November 21). Quest Database™ cAMP-dependent protein kinase (PKA) Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/camp-dependent-protein-kinase-pka-inhibitors-ic50-ki.
BibTeXEndNoteRefMan